If Neuroendocrine Cancer Has Spread, Why Would Surgery Still Be Considered?
July 16, 2026
By Anna C. Greene, PhD, NETRF Chief Scientific Officer When someone is diagnosed with metastatic
$42.8M
 in neuroendocrine cancer research funding
171
Funded Research
Projects
17
Countries with ongoing studies
By Anna C. Greene, PhD, NETRF Chief Scientific Officer When someone is diagnosed with metastatic
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Patients often hear similar-sounding terms: neuroendocrine
NETRF BOSA Leadership Transition The Neuroendocrine Tumor Research Foundation is pleased to share updates on
You can support a brighter future. Make a gift. Host an event. Or volunteer to help us advance our understanding of neuroendocrine cancer.
Learn about neuroendocrine cancer tests, treatments, and research. Find out about educational and inspirational events in the neuroendocrine cancer community.
NETRF hosts free patient and caregiver neuroendocrine cancer conferences to educate and empower individuals to be part of their care planning and live their best life.